subcutaneously into nude mice. The latent period of tumour formation at the inoculation site as well as final tumour size and metastatic performance at autopsy, 140 days after inoculation, were then assessed. The prevaknce of metastasis of the parent, polyclonal, cell line and of its metastatic clones was increased if the cell inoculum was mixed with Matrigel. Non-metastatic clones were not induced to become metastatic by this treatment, but local tumour growth at the site of inoculation was enhanced in all experimental groups receiving Matrigel. Orthotopic inoculation acted synergistically with Matrigel to maximise both tumour growth and metastatic behaviour. The composition of the local extracellular matrix at the site of tumour growth influenced expression of the metastatic phenotype by cells which are constitutionally capable of this behaviour, but did not induce it in ones which are not. Previous reports that local tumour growth is facilitated by enrichment of the mesenchymal matrix are confirmed. The mechanisms by which such effects are exerted are worthy of study, to ascertain whether they might be subject to clinical manipulation designed to retard tumour growth and dissemination.
The discovery that mutant athymic nude mice do not reject heterotransplants of human tumour tissue (Rygaard & Povlsen, 1969 ) provided new opportunities for experimental studies on human tumours, including the analysis of their metastatic properties. However, several subsequent reports noted that the prevalence of tumour formation by xenografted fresh primary human tumour fragments in nude mice is low, approximately 30% (Sharkey & Fogh, 1984) , although the 'take rate' with passaged tumour cell lines (Fogh et al., 1977) and with tissues from metastases (Sharkey & Fogh, 1984) is about double this. Also, many tumour implants and cell lines, including those derived from highly malignant human cancers, fail to form metastases in adult nude mice, even if they do grow at the site of implantation (Sharkey & Fogh, 1978; Fidler, 1986) and the animals are expensive, delicate and highly susceptible to infection. These difficulties have impeded and delayed extensive use of nude mouse xenografts in research on mechanisms of human tumour metastasis. Even so, the goal of being able to study this event in a living host has motivated investigators to persist in efforts to induce human tumour cells to re-enact the metastatic process in experimental animals. Variables that have been found to affect whether metastasis occurs include the health and housing conditions of the mice (Sharkey & Fogh, 1978; Neulat-Duga et al., 1984; Fidler, 1986) , the level of natural killer (NK)-cell activity, age of the host (Fidler, 1986) and the route of tumour cell inoculation (Kozlowski et al., 1984; Giavazzi et al., 1986) , in addition to the intrinsic properties of the tumours under investigation.
Of the several human tumour types now becoming available for the study of metastasis in the nude mouse, one of the most interesting for future study is the MDA-MB-435 cell line isolated from a pleural effusion in a patient with breast cancer (Caillou et al., 1978) . Price et al. (1990) reported that orthotopic implantation of cells of this line into the mammary fat pad (mfp) of nude mice could enhance its tumorigenicity in this host, and these tumours were found to be more metastatic than those formed after subcutaneous inoculation. These findings confirm and extend similar observations, reported in recent years (Bresalier et al., 1987; Morikawa et al., 1988) , with colon carcinoma cell lines. Tumours formed by these cell lines following intramural injection in the colon are more metastatic than those resulting from subcutaneous inoculation. An orthotopic microenvironment evidently encourages tumour cells to express the malignant phenotype (See also Fidler, 1990 (Fridman et al., 1990 (Fridman et al., , 1991 Pretlow et al., 1991) (DMEM) supplemented with 5% newborn calf serum, sodium pyruvate, L-glutamine (2mM), non-essential amino acid and 2 x vitamin solution (Gibco). The cultures were incubated at 37C in a humidified atmosphere of 5% carbon dioxide-95% air. Tumour cells were harvested by washing the monolayer with phosphate-buffered saline (PBS) followed by brief incubation in 0.25% trypsin-0.02% EDTA at 3rC. The cells were then washed by centrifugation and resuspended in DMEM in preparation for inoculation. Clones Cl to C4 were chosen for use in this study on the basis of earlier assays of their metastatic capabilities (see below) when injected suspended in culture medium alone.
Matrigel
Matrigel was extracted from fresh pieces of the mouse Englebreth-Hohm-Swarm (EHS) tumour as described previously (Kleiman et al., 1986 (Kleiman et al., , 1990 (Fridman et al., 1990 (Fridman et al., , 1991 Pretlow et al., 1991) . In the present study we found that Matrigel facilitated not only the growth but also the metastasis of tumours formed by the human breast carcinoma line MDA-MB-435 in nude mice and by some of the clones derived from it. From this body of data it is evident that a judicious choice of tumour cell line, site of inoculation and facilitatory, mesenchymally derived, tissue constituents can now enable an investigator reliably to observe and analyse the metastatic spread of human tumour cells in the body of the nude mouse.
At present, there is insufficient information available to define the active components in Matrigel which affect tumour growth and metastasis formation. Laminin, the major constituent of Matrigel, has been shown to accelerate the attachment, activation and growth of tumour cells (Fridman et al., 1990 (Fridman et al., , 1991 , and to increase tumour metastases when injected intravenously with B16F1O melanoma cells (Barsky et al., 1984; Terranova et al., 1984) . However, I in in alone does not promote tumour growth as effectively as Matrigel in the s.c. site (Fridman et al., 1990) . Collagen IV, entactin and heparan sulphate proteoglycan are also biologically active and may contribute to the growth, adhesion, spreading and motility of tumour cells (Aumailley & Timpl, 1986; Clement et al., 1989; Chakravarti et al., 1990) . Further experiments involving sequential addition of such components to laminin in the medium in which the inoculated cells are suspended could help to analyse which of these constituents of Matrigel mediates its faclitatory effects on metastasis. The physical consistency of Matrigel is also more viscous than that of culture medium, and this may make some contribution to its observed effects. It is possible that this inhibits scattering of tumour cells after inoculation and thereby promotes relevant interactions between themselves and with surrounding cells (see below).
Recent studies with different human and murine tumour cell lines have shown that the site of inoculation can influence whether distant metastases are formed (Ahlering et al., 1987; Bresalier et al., 1987; Morikawa et al., 1988; Price et al., 1990) , although it is not clear how the local tissue environment exerts this effect. The present work confirms that the mfp is a more favourable site than the subcutis for the growth of mammary tumours (Miller et al., 1981; Price et al., 1990) , and also for the expression of metastatic ability, there being a higher frequency of metastasis from the mfp tumours. Matrigel and mfp inoculation acted synergistically to facilitate all cell lines to produce larger tumours but did not induce the non-metastatic clones C3 and C4 to become metastatic, although the prevalence of metastasis by the parent line and by metastatic clones Cl and C2 was increased. Such findings indicate that pulmonary metastasis after inoculation, either s.c. or mfp, or with Matrigel, primarily depends on intrinsic properties of the tumour cells (Fidler, 1978; Tarin & Prince, 1979) , but can be modulated by local microenvironmental factors. Recent results (Steeg et al., 1988; Hayle et al., 1993) indicate that metastatic events occur as a result of genetic disturbances which allow the inappropriate expression of genes that are silent in most cells, enabling the cells affected and their progeny to disseminate from the primary site. This new evidence suggests that metastasis may occur as a consequence either of failure of a negative regulatory event responsible for inhibiting inappropriate cell migration and distant colonisation, perhaps involving the nm23 gene (Steeg et al., 1988) , or of the activation and up-regulation of a gene capable of dominantly conferring the phenotype (Hayle et al., 1993) . In any event, once this balance has been disturbed, it appears that microenvironmental influences, such as the site of growth of the tumour cells or the constitution of the adjacent tissue matrix, can accelerate tumour growth and dissemination. The mechanisms by which this effect is mediated deserve further investigation, to ascertain whether they might be susceptible to pharmacological hindrance, which could have the dual clinical benefit of retarding the growth of secondary tumours as well as impeding further dissemination.
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